US EditionPublished • loading... • Updated
Sus Offers Vaccine Against Bronquiolitis for Premature Babies
Summary by EBC
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
From this month, premature babies and with comorbidities will be able to receive vaccine against bronquiolitis in the Single Health System (SUS). The medicine offered is nirsevimabe, which extends protection against the Respiratory Synthetic Virus (VSR), the main cause of the disease. The Ministry of Health explains that nirsevimabe is a monoclonal antibodies capable of providing immediate protection. There is no need, in this case, to stimulate…
·Quadra, Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
